| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Sep―17 |
Multivalent decoy receptor therapeutics to combat viral pandemics and evolution |
Alex Odoom, Eugene M. Obeng, Christian K.O. Dzuvor |
| 2 |
[GO] |
2025―May―16 |
The frameshifting element in coronaviruses: structure, function, and potential as a therapeutic target |
Qi Li, Qian Wang, Rui Wang, Liangren Zhang, Zhenming Liu |
| 3 |
[GO] |
2022―Sep―26 |
Pharmacokinetic Considerations to Optimize Clinical Outcomes for COVID-19 Drugs |
Chukwunonso K. Nwabufo, Reina Bendayan |
| 4 |
[GO] |
2022―Sep―07 |
Lessons from Covid-19 to increase opioid vaccine acceptance |
Roxana Damiescu, Mita Banerjee, Norbert W. Paul, Thomas Efferth |
| 5 |
[GO] |
2022―Aug―24 |
Targeting SARS-CoV-2 Papain-Like Protease in the Post-Vaccine Era |
Anh-Tien Ton, Mohit Pandey, Jason R. Smith, Fuqiang Ban, Michael Fernandez, Artem Cherkasov |
| 6 |
[GO] |
2022―Apr―18 |
Thapsigargin: key to new host-directed coronavirus antivirals? |
Mohammed Samer Shaban, Christin Mayr-Buro, Johanna Meier-Soelch, Benadict Vincent Albert, M. Lienhard Schmitz, John Ziebuhr, Michael Kracht |
| 7 |
[GO] |
2022―Feb―28 |
A decoy mutant ACE2 designed to reduce COVID-19 |
Mazharul Maishan, Diana L. Lim, Guy A. Zimmerman, Michael A. Matthay |
| 8 |
[GO] |
2021―Oct―21 |
Apart, Together: Reflections on the COVID-19 Pandemic |
Jerry Madukwe |
| 9 |
[GO] |
2021―Mar―26 |
Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19 |
Tahsin F. Kellici, Ewa S. Pilka, Michael J. Bodkin |
| 10 |
[GO] |
2020―Jul―31 |
Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2 |
Alex Renn, Ying Fu, Xin Hu, Matthew D. Hall, Anton Simeonov |
| 11 |
[GO] |
2020―Jul―14 |
Can activation of NRF2 be a strategy against COVID-19? |
Antonio Cuadrado, Marta Pajares, Cristina Benito, José Jiménez-Villegas, Maribel Escoll, Raquel Fernández-Ginés, et al. (+5) Angel J. Garcia Yagüe, Diego Lastra, Gina Manda, Ana I. Rojo, Albena T. Dinkova-Kostova |
| 12 |
[GO] |
2020―Jun―20 |
Deciphering the TCR Repertoire to Solve the COVID-19 Mystery |
Lucas Gutierrez, John Beckford, Houda Alachkar |
| 13 |
[GO] |
2020―Jun―17 |
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19 |
Wei Luo, Yi-Xin Li, Li-Jun Jiang, Qian Chen, Tao Wang, Da-Wei Ye |
| 14 |
[GO] |
2020―May―30 |
and Animal Models for SARS-CoV-2 research |
Kazuo Takayama |
| 15 |
[GO] |
2020―May―20 |
Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-analysis |
Zhongren Ma, Jiaye Liu, Qiuwei Pan |
| 16 |
[GO] |
2020―Apr―09 |
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic |
Mark P. Lythgoe, Paul Middleton |
